Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients

Deciphera Pharmaceuticals’ Qinlock (ripretinib) received the US FDA approval for advanced GIST

FDA approved Novartis’ Tabrecta for NSCLC with METex14

PFIZER AND BIONTECH STARTS THE CLINICAL TRIALS OF COVID-19 VACCINE

AstraZeneca’s approved Koselugo by US FDA for neurofibromatosis type 1

FDA approved a new treatment for a rare soft tissue cancer, epithelioid sarcoma

Trump administration takes first step in implementing provisional law to control drug prices

New study showed that rural Americans have less access to mental health and hospital services

AstraZeneca’s Farxiga received fast track designation from US FDA

Novartis capmatinib (INC280) received breakthrough designation by FDA

FDA approved Kyowa Kirin’s Nourianz for adults with Parkinson’s disease

FDA approved AbbVie’s Rinvoq for treatment of moderately to severe rheumatoid arthritis

US FDA approved Merck's Recarbrio for adults with cUTI and cIAI

US FDA approved Merck's Keytruda for two more target populations in patients suffering from HNSCC